Sofinnova Investments’s Foamix Pharmaceuticals FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-1,162,176
Closed -$3.87M – 77
2019
Q4
$3.87M Sell
1,162,176
-37,078
-3% -$118K 0.28% 48
2019
Q3
$3.64M Buy
1,199,254
+83,444
+7% +$235K 0.33% 47
2019
Q2
$2.66M Buy
1,115,810
+283,517
+34% +$847K 0.24% 49
2019
Q1
$3.12M Hold
832,293
– – 0.3% 50
2018
Q4
$2.99M Buy
832,293
+163,674
+24% +$712K 0.37% 46
2018
Q3
$3.83M Sell
668,619
-13,780
-2% -$78.8K 0.34% 43
2018
Q2
$3.42M Buy
682,399
+610,382
+848% +$3.14M 0.39% 43
2018
Q1
$369K Hold
72,017
– – 0.06% 37

Sofinnova Investments's FOMX Position: Q1 2020 in Review

Sofinnova Investments sold out of Foamix Pharmaceuticals (FOMX) in Q1 2020, closing a stake of 1,162,176 shares — an estimated $3.87M sold.

Sofinnova Investments first reported a position in FOMX in Q1 2018 and held it in 8 quarters. The position peaked at $3.87M in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Sofinnova Investments reported no remaining Foamix Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Sofinnova Investments sold 1,162,176 Foamix Pharmaceuticals shares in Q1 2020, an estimated $3.87M.
  • Sofinnova Investments first reported a position in Foamix Pharmaceuticals in Q1 2018 and held it in 8 quarters.
  • Sofinnova Investments's Foamix Pharmaceuticals position peaked at $3.87M in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals as of Q1 2020.

Based on Sofinnova Investments's 13F filing for Q1 2020, filed 13 May 2020.